Release Date: 28/11/17 14:01 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 88.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%